Actualidad
CNN CHILE · TERAPIA NEURAL (VIDEO)
DISAUTONOMIA en pacientes post-COVID y Terapia Neural (VIDEO)
Local anesthetics as a therapeutic tool for post COVID-19 patients A case report
Bases Científicas de la Terapia Neural: Therapeutic Use of Low-Dose Local Anesthetics in Pain, Inflammation, and Other Clinical Conditions: Scoping…
Diplomatura Univ en Terapia Neural Veterinaria 2024
CURSO NERVISMO RUSO - Bogotá Mayo 2024 (Presencial y Virtual)
Formación en Odontología Sistémica - 2024
USA Seattle APR 2024 - North American Academy of NT Conference
Newsletters
UTERINE CONTRACTILITY CHANGES WITH LOCAL ANESTHETICS
- Detalles
- Escrito por F Weinschenk
Abstract
Background
Local anesthetics (LAs) are increasingly used as therapeutics due to their multiple molecular effects. They may be potential agents also in gynecology and reproductive medicine. The objective of this study was to investigate the contractility response of the perfused swine uterus to different concentrations of the LAs procaine, lidocaine, and ropivacaine.
Methods and findings
In an extracorporeal perfusion model with fresh swine uteri, effects of administered boli of these three LAs in concentrations of 0.1 mg/mL, 0.5 mg/mL and 1.0 mg/mL on uterine contractility and peristalsis were assessed using an intrauterine double-chip micro-catheter. A dose-dependent increase in intrauterine pressure (IUP) in the isthmus and corpus uteri were observed after the administration of the ester-LA procaine 0.1, 0.5, and 1.0%, which was not seen with lower concentrations or buffer solution. An increase-decrease curve was found after increasing concentrations of the amide-LA lidocaine and ropivacaine, with an IUP plateau with 0.1 and 0.5%, and a decrease with 1% (p<0.01). All reactions were seen in both the isthmus and corpus uteri. The difference of the contractility pattern between ester- and amide-LA at 1% concentration was significant.
Conclusion
LAs dose-dependently modulates contractility in non-pregnant swine uteri. The amid-LAs lidocaine and ropivacaine reduce contractility in higher concentrations and may be used as therapeutics in disorders with increased uterine contractility, as dysmenorrhoea, endometriosis, and infertility. The multiple molecular effects of LAs may explain these effects. This in-vitro pilot study in vitro provides initial data for designing further studies to transfer the results onto humans.
See FREE complete PDF
.